AKT1 and systemic lupus erythematosus: Treatment With hUC‐MSCs Modulated SLE‐CD4+ T Cell Inflammatory Factors Production by Reinstating Overactive Glucose Metabolism via HSP90AA1 in the PI3K‐AKT Pathway